DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Razadyne (Galantamine Hydrobromide) - Current Clinical Trials

 
 



Razadyne Related Clinical Trials

Effect of Galantamine on Smoking Abstinence [Completed]

A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease [Completed]

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) [Completed]

Galantamine Effects on Cognitive Function in Abstinent Cocaine Users [Completed]

Galantamine Effects on Nicotine Responses in Smokers [Completed]

Galantamine and Memantine for Cognitive Impairments in Schizophrenia [Recruiting]

Effects of Galantamine on Cognition [Recruiting]

Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder [Completed]

The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning [Completed]

Effect of Galantamine on Short-term Abstinence [Recruiting]

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse [Completed]

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions [Completed]

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions [Completed]

Efficacy of Galantamine to Treat Schizophrenia [Terminated]

Galantamine Treatment for Nonfluent Aphasia in Stroke Patients [Completed]

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition [Completed]

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition [Completed]

Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine [Recruiting]

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease [Completed]

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period [Completed]

The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life [Completed]

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia [Completed]

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease [Completed]

Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia [Completed]

Galantamine Effects on Cognitive Function in Marijuana Users [Completed]

A Study to Help People Quit Smoking. [Recruiting]

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers [Completed]

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease [Completed]

Galantamine Effects in Patients With Metabolic Syndrome [Active, not recruiting]

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine [Completed]

A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease [Terminated]

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease [Completed]

Characteristics of Treatment Responders to Galantamine [Completed]

Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment [Recruiting]

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease [Terminated]

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [Completed]

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil [Completed]

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients [Terminated]

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease [Completed]

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine [Completed]

Cognitive Enhancement as a Target for Cocaine Pharmacotherapy [Recruiting]

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial [Terminated]

A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Completed]

Galantamine for Cognitive Deficits in Schizophrenia [Completed]

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease [Completed]

Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance [Completed]

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease [Completed]

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease [Completed]

Treatment of Tardive Dyskinesia With Galantamine [Completed]

A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease [Completed]

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type [Completed]

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies [Completed]

A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Completed]

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment [Completed]

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation [Completed]

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Completed]

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Completed]

Alzheimer and Sleep [Completed]

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study [Completed]

A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia. [Completed]

Galantamine Versus Placebo in Childhood Autism [Completed]

Safety Study of Galantamine in Tic Disorders [Terminated]

Evaluation of Galantamine in the Treatment of Alzheimer's Disease [Completed]

Galantamine for Cognition in People With Schizophrenia [Completed]

Galantamine Executive Function in Parkinson's Disease [Active, not recruiting]

A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder [Active, not recruiting]

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (ReminylŪ) [Recruiting]

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia [Completed]

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease. [Completed]

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. [Completed]

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia [Completed]

Racial Differences in Vagal Control of Glucose Homeostasis [Not yet recruiting]

An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms [Completed]

Symptomatic Treatment of Vascular Cognitive Impairment [Recruiting]

Galantamine in the Treatment of Post-Traumatic Headache [Recruiting]

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease [Completed]

Comparative Research of Alzheimer's Disease Drugs [Active, not recruiting]

Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder [Completed]

Effect of Galantamine on Short-term Abstinence [Recruiting]

Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke [Completed]

Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease [Completed]

Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD) [Active, not recruiting]

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease [Active, not recruiting]

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease [Completed]

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) [Active, not recruiting]

Pharmacovigilance in Gerontopsychiatric Patients [Recruiting]

MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy [Active, not recruiting]

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors [Completed]

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease [Recruiting]

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Completed]

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease [Completed]

A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease [Completed]

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Completed]

Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017